← Back to Clinical Trials
Recruiting NCT07236840

Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition CNS Tumor
Sponsor Tata Memorial Centre
Study Type OBSERVATIONAL
Phase N/A
Enrollment 600
Sex ALL
Min Age 5 Years
Max Age N/A
Start Date 2026-02-20
Completion 2027-11-01
Interventions
Neurological assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational study is to evaluate the feasibility and accuracy of a self-administered remote neurological examination using the "Iskhaa" mobile application in patients with brain tumors aged above 5 years who are able to follow app-based instructions. The main questions it aims to answer are: 1. Development of a mobile application equipped with symptom assessment and recording videos as patients perform specific neurological tasks. 2. Development and validation of the AI model to detect functional changes and predict subsequent neurological deterioration. Participants will: 1. Use the Iskhaa mobile application to perform guided self-neurological examinations following pre-recorded video instructions. 2. Complete EORTC QLQ-C30 and BN20 questionnaires for quality of life assessment. 3. Record and upload videos (e.g., speech, walking, limb movements) using their mobile camera for analysis. 4. In Phase 1 (onsite), 100 participants will use the app under supervision to ensure usability and accuracy. 5. In Phase 2 (offsite), 500 participants will use the app independently at home for monthly self-assessments, with reminders and follow-up support. 6. Continue routine clinic visits every 3-6 months and imaging every 6-12 months as per standard clinical care. The study will compare app-recorded data with physician assessments to determine agreement and validity of remote neurological monitoring using artificial intelligence analysis.

Eligibility Criteria

Inclusion Criteria: 1. Diagnosis of brain tumors (histopathology/ radiology). 2. Age \> 5 years 3. Patient or caregiver have access to an android smart phone and is able to install the mobile application. 4. Expected survival more than 6 months during study accrual. 5. Signing patient consent or parent consent/ child assent form (as appropriate). Exclusion Criteria: 1. Patient or caregiver is not reliable to follow instructions or use the mobile application. 2. Patient with severe cognitive or psychiatric issues causing difficulty in using the app or follow instructions. 3. Karnofsky Performance Status (KPS) or Lansky Performance Status LPS) \<50. 4. Terminal illness with expected life expectancy (\<6 months).

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}